CD33 and acute myeloid leukemia: Overall, these data demonstrate that M2T-CD33 induces a prominent CD33-specific polyclonal humoral response that utilizes the full spectrum of Ig isotypes, recognizes natively expressed CD33 on human AML cells, and has cytotoxic function against CD33-positive AML cells.